SEOM小细胞肺癌治疗临床指南。 - Suppr

SEOM clinical guidelines for the treatment of small-cell lung cancer.

作者信息

Artal Cortés Angel, Dómine Gómez Manuel, Font Pous Albert, García Campelo Rosario, Cobo Dolls Manuel, Isla Casado Dolores

机构信息

Servicio de Oncología Médica, Hospital Universitario Miguel Servet, Zaragoza, Spain.

出版信息

Clin Transl Oncol. 2010 Jan;12(1):27-31. doi: 10.1007/s12094-010-0463-2.

DOI:10.1007/s12094-010-0463-2

PMID:20080468

Abstract

摘要

相似文献

SEOM clinical guidelines for the treatment of small-cell lung cancer.SEOM小细胞肺癌治疗临床指南。

Clin Transl Oncol. 2010 Jan;12(1):27-31. doi: 10.1007/s12094-010-0463-2.

SEOM clinical guidelines for the treatment of small-cell lung cancer 2013.SEOM 临床指南：2013 年小细胞肺癌治疗

Clin Transl Oncol. 2013 Dec;15(12):985-90. doi: 10.1007/s12094-013-1086-1. Epub 2013 Sep 5.

Lung Cancer OncoGuia.肺癌诊疗指南

Clin Transl Oncol. 2009 Dec;11(12):805-24. doi: 10.1007/s12094-009-0449-0.

[Advances on treatment of limited-disease small cell lung cancer].[局限期小细胞肺癌的治疗进展]

Zhongguo Fei Ai Za Zhi. 2011 Oct;14(10):811-8. doi: 10.3779/j.issn.1009-3419.2011.10.08.

Bronchioalveolar lung cancer: screening and overdiagnosis.细支气管肺泡癌：筛查与过度诊断

J Clin Oncol. 2014 Nov 1;32(31):3575. doi: 10.1200/JCO.2014.55.9732. Epub 2014 Sep 15.

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.小细胞肺癌：欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访

Ann Oncol. 2010 May;21 Suppl 5:v120-5. doi: 10.1093/annonc/mdq172.

[Advances about treatment of small cell lung cancer].[小细胞肺癌的治疗进展]

Zhongguo Fei Ai Za Zhi. 2011 Oct;14(10):819-24. doi: 10.3779/j.issn.1009-3419.2011.10.09.

Reply to A. Braillon.回复A. 布拉永。

J Clin Oncol. 2014 Nov 1;32(31):3575. doi: 10.1200/JCO.2014.57.2545. Epub 2014 Sep 15.

Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.影响广泛期小细胞肺癌胸内进展风险的预后因素。

BMC Cancer. 2016 Mar 8;16:197. doi: 10.1186/s12885-016-2222-4.

Recent clinical advances in lung cancer management.肺癌管理的最新临床进展。

J Clin Oncol. 2014 Apr 1;32(10):973-82. doi: 10.1200/JCO.2013.53.1228. Epub 2014 Feb 24.

引用本文的文献

The role of immunotherapy in small cell lung cancer.免疫疗法在小细胞肺癌中的作用。

Clin Transl Oncol. 2019 Aug;21(8):961-976. doi: 10.1007/s12094-018-02011-9. Epub 2019 Jan 12.

The relevance of the Spanish Society for Medical Oncology (SEOM)'s clinical oncology guidelines.西班牙医学肿瘤学会（SEOM）临床肿瘤学指南的相关性。

Clin Transl Oncol. 2010 Nov;12(11):707-8. doi: 10.1007/s12094-010-0582-9.

本文引用的文献

Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0402.在既往接受过治疗的小细胞肺癌患者中比较氨柔比星与拓扑替康的随机II期试验：日本北部肺癌研究组试验0402

J Clin Oncol. 2008 Nov 20;26(33):5401-6. doi: 10.1200/JCO.2008.18.1974. Epub 2008 Oct 14.

Platinum versus non-platinum chemotherapy regimens for small cell lung cancer.用于小细胞肺癌的铂类与非铂类化疗方案

Cochrane Database Syst Rev. 2008 Oct 8(4):CD006849. doi: 10.1002/14651858.CD006849.pub2.

Prophylactic cranial irradiation in extensive small-cell lung cancer.广泛期小细胞肺癌的预防性全脑照射

N Engl J Med. 2007 Aug 16;357(7):664-72. doi: 10.1056/NEJMoa071780.

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.过去30年美国小细胞肺癌流行病学的变化：监测、流行病学和最终结果数据库分析

J Clin Oncol. 2006 Oct 1;24(28):4539-44. doi: 10.1200/JCO.2005.04.4859.

Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.一项开放标签、多中心、随机、III期研究，比较口服拓扑替康/顺铂与依托泊苷/顺铂作为初治广泛期小细胞肺癌患者的治疗方案。

J Clin Oncol. 2006 May 1;24(13):2044-51. doi: 10.1200/JCO.2005.03.3332.

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.一项随机III期试验，比较伊立替康/顺铂与依托泊苷/顺铂用于先前未治疗的广泛期小细胞肺癌患者的疗效。

J Clin Oncol. 2006 May 1;24(13):2038-43. doi: 10.1200/JCO.2005.04.8595.

Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.化疗第一天至胸部放疗最后一天之间的时间是局限期小细胞肺癌生存的最重要预测因素。

J Clin Oncol. 2006 Mar 1;24(7):1057-63. doi: 10.1200/JCO.2005.02.9793.

Prospective randomized phase III trial of etoposide/cisplatin versus high-dose epirubicin/cisplatin in small-cell lung cancer.依托泊苷/顺铂对比高剂量表柔比星/顺铂用于小细胞肺癌的前瞻性随机III期试验

Clin Lung Cancer. 2004 Nov;6(3):175-83. doi: 10.3816/clc.2004.n.031.

Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.顺铂和依托泊苷方案在小细胞肺癌治疗中优于环磷酰胺、表柔比星和长春新碱方案：一项5年随访的随机III期试验结果

J Clin Oncol. 2002 Dec 15;20(24):4665-72. doi: 10.1200/JCO.2002.12.111.

A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis.一项关于依托泊苷和顺铂在小细胞肺癌化疗中作用的系统评价，并进行方法学评估和荟萃分析。

Lung Cancer. 2000 Oct;30(1):23-36. doi: 10.1016/s0169-5002(00)00127-6.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SEOM clinical guidelines for the treatment of small-cell lung cancer.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献